Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma

相似書籍

• Drug Resistance to Inhibitors of the Human Double Minute-2 E3 Ligase is Mediated by Point Mutations of p53, but can be Overcome with the p53 Targeting Agent RITA
  由: Jones, Richard J., et al.
  出版: (2012)
• Truncated protein tyrosine phosphatase receptor type O suppresses AKT signaling through IQ motif containing GTPase activating protein 1 and confers sensitivity to bortezomib in multiple myeloma
  由: Wang, Hua, et al.
  出版: (2017)
• A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis
  由: Chen, Shuang, et al.
  出版: (2014)
• Bortezomib and EGCG: no green tea for you?
  由: Shah, Jatin J., et al.
  出版: (2009)
• Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
  由: Kuhn, Deborah J., et al.
  出版: (2009)